ET-traps as a potential treatment for COVID-19
The ET-traps are Fc-fusion proteins that have shown a therapeutic potential in the diabetes disease space. Previous studies have also discussed the potential use of ET-traps for other diseases, including HIV / AIDS. These diseases are all associated with pathologically elevated endothelin −1 (ET-1)...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The ET-traps are Fc-fusion proteins that have shown a therapeutic potential in the diabetes disease space. Previous studies have also discussed the potential use of ET-traps for other diseases, including HIV / AIDS. These diseases are all associated with pathologically elevated endothelin −1 (ET-1) levels. This paper discusses the potential use of ET-traps for the COVID-19 pandemic, which previous studies have shown involves high cytokine levels. Research has also shown that ET-1 is a stimulus for the induction of these pro-inflammatory cytokines. Hence, the ET-traps would likely be effective in patients suffering from COVID-19. If successful at the preclinical and clinical testing, the ET- traps would provide a much-awaited therapy. |
|---|---|
| Item Description: | 2590-0986 10.1016/j.medidd.2020.100054 |